Back
Daxor 10K Form
Sell
23
DXR
Daxor
Last Price:
8.14
Seasonality Move:
11.73%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2012-03-28 | 10K | DXR/Daxor Annual |
| 2011-11-14 | 10Q | DXR/Daxor Quarterly |
| 2011-08-31 | 10Q | DXR/Daxor Quarterly |
| 2011-08-09 | 10Q | DXR/Daxor Quarterly |
| 2011-05-13 | 10Q | DXR/Daxor Quarterly |
| 2011-03-29 | 10K | DXR/Daxor Annual |
Receive DXR News And Ratings
See the #1 stock for the next 7 days that we like better than DXR
DXR Financial Statistics
Sales & Book Value
| Annual Sales: | $1.28M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $6.75 |
| Price / Book: | 1.2 |
Profitability
| EPS (TTM): | 0.30030 |
|---|---|
| Net Income (TTM): | $1.69M |
| Gross Margin: | -- |
| Return on Equity: | 5.22% |
| Return on Assets: | 5.08% |
Daxor Earnings Forecast
Key Daxor Financial Ratios
- Per Share Earnings over the last 39 years have been positive in 16 years.
Daxor Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | DXR |
| CUSIP: | 239467 |
| Website: | daxor.com |
Debt
| Debt-to-Equity Ratio: | 0.05 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 58 |
|---|---|
| Forward P/E Ratio: | 0 |